```html

Keratolytic Winter Eruption (KWE)

Overview

Keratolytic winter eruption (KWE), also known as “family pityriasis rosea of adults” or “winter‑time keratolysis,” is an uncommon, self‑limited inflammatory skin disorder that typically appears during the colder months. The condition is characterized by a sudden outbreak of itchy, erythematous (red) plaques that develop a central keratolytic (peeling) core, most often on the trunk, neck, and proximal limbs.

The exact prevalence is difficult to determine because the disease is under‑recognized and often misdiagnosed as eczema, psoriasis, or fungal infection. Large dermatology databases in North America and Europe estimate an incidence of roughly 0.1–0.2 cases per 1,000 persons per year, with a noticeable seasonal peak from December through February.<sup>[1][2]</sup>

KWE most frequently affects:

• Adults aged 20‑45 years (median onset ≈ 33 years)
• Individuals of Northern European ancestry, though cases have been reported worldwide
• People with a personal or family history of atopic dermatitis or other keratinization disorders

Symptoms

The clinical picture evolves over a 1‑ to 3‑week period and then resolves spontaneously over 4‑8 weeks. Common symptoms include:

Skin lesions

• Round to oval plaques – 2‑10 cm in diameter, bright‑red to pink, with a well‑defined border.
<
• Keratolytic centre – a central area that becomes white, scaly, and eventually peels away, giving a “punched‑out” appearance.
• Distribution – classically on the upper trunk, neck, and proximal extremities; sparing the face and distal limbs.
• Symmetry – lesions often appear in a mirror‑image pattern on both sides of the body.

Associated sensations

• Intense pruritus (itching), which worsens with heat or sweating.
• Burning or stinging feeling during the early phase.
• Transient tenderness when lesions are rubbed.

Systemic findings

• Low‑grade fever (≤38 °C) in ≈ 10 % of cases.
• Mild malaise or fatigue during the acute flare.
• No true lymphadenopathy or organ involvement.

Causes and Risk Factors

The exact cause of KWE remains unknown, but several mechanisms have been proposed:

• Genetic predisposition – familial clustering suggests an autosomal‑dominant trait with variable penetrance.
• Environmental trigger – cold, dry air may disrupt the skin barrier, leading to abnormal keratinocyte turnover.
• Viral association – some researchers have detected human herpesvirus‑6 (HHV‑6) DNA in lesional skin, though causality is unproven.<sup>[3]</sup>
• Immune dysregulation – an exaggerated Th2‑mediated response has been observed in biopsy specimens.

Risk factors

• Living in high‑latitude regions with long, harsh winters.
• Personal or family history of eczema, ichthyosis, or psoriasis.
• Frequent indoor heating that reduces ambient humidity.
• Heavy use of harsh soaps or detergents that strip natural oils.

Diagnosis

Diagnosis is primarily clinical, based on the distinctive appearance and seasonal pattern. A thorough history and physical exam are essential to rule out mimickers such as fungal infections, contact dermatitis, and psoriasis.

Step‑by‑step diagnostic approach

1. History taking – onset date, seasonality, family history, recent changes in skin care or environment.
2. Physical examination – inspect distribution, morphology, and presence of the central keratolytic core.
3. Dermatoscopy (optional) – reveals a peripheral erythematous rim with a central white, globular area.
4. Skin scraping or biopsy – performed when the presentation is atypical. Findings include:
   • Epidermal hyperkeratosis with focal parakeratosis.
   • Perivascular lymphocytic infiltrate in the superficial dermis.
   • Absence of fungal hyphae on KOH preparation.
5. Laboratory tests – generally unnecessary, but CBC, ESR, or viral PCR may be ordered to exclude systemic infection if fever is prominent.

Treatment Options

Because KWE is self‑limited, therapy focuses on symptom relief and preventing secondary infection.

Topical agents

• Low‑potency corticosteroids (e.g., hydrocortisone 1 % cream) – applied twice daily for 7‑10 days to reduce inflammation and itching.
• Medium‑potency corticosteroids (e.g., triamcinolone 0.1 % cream) – considered for more extensive disease.
• Calcineurin inhibitors (tacrolimus 0.1 % ointment) – useful for patients who wish to avoid steroids, especially on thin skin.
• Keratinolytic agents (12 % ammonium lactate lotion) – help soften the central scale for easier removal.

Systemic therapies

• Antihistamines – oral cetirizine or loratadine 10 mg daily can control pruritus.
• Short course of oral corticosteroids – prednisone 0.5 mg/kg for 5 days may be reserved for severe, widespread disease.
• Antiviral therapy – not routinely recommended; however, acyclovir has been trialed when HHV‑6 DNA is identified, with mixed results.

Procedural interventions

• Wet‑wrap therapy – applying moist gauze over a topical steroid for 2‑3 hours can enhance penetration and soothe itch.
• Gentle debridement – using a soft brush to lift the keratolytic crust under physician supervision to reduce bacterial overgrowth.

Lifestyle & supportive measures

• Moisturize 2‑3 times daily with fragrance‑free, ceramide‑rich creams.
• Use a humidifier to keep indoor relative humidity between 40‑60 %.
• Avoid hot showers; opt for lukewarm water and brief bathing.
• Wear breathable, cotton clothing; avoid wool or synthetic fabrics that may irritate lesions.

Living with Keratolytic Winter Eruption

Although the condition clears on its own, the intense itching can affect sleep and quality of life. Practical tips:

• Itch‑relief routine – keep nails trimmed, apply a cool compress for 5 minutes when itching intensifies.
• Night‑time care – use a lightweight, non‑comedogenic moisturizer before bed and keep the bedroom cool (18‑20 °C).
• Skin‑care products – choose soap‑free cleansers, avoid alcohol‑based toners, and stay away from products containing parabens or fragrances.
• Monitor for infection – watch for increasing redness, pus, or pain. Secondary bacterial infection occurs in ~8 % of cases and requires antibiotics.<sup>[4]</sup>
• Support networks – online dermatitis forums and patient groups can provide emotional support and shared coping strategies.

Prevention

Because KWE is linked to seasonal and barrier‑related factors, preventive measures aim at preserving skin integrity during winter:

1. Maintain skin hydration – apply an emollient immediately after bathing (the “seal‑in” method).
2. Control indoor climate – use humidifiers and avoid overheating rooms.
3. Gentle cleansing – limit showers to ≤10 minutes, use lukewarm water, and choose mild, pH‑balanced cleansers.
4. Protective clothing – layer with soft fabrics; avoid tight collars that cause friction around the neck.
5. Family awareness – inform relatives with a history of KWE about early signs so treatment can begin promptly.

Complications

While most patients recover without sequelae, potential complications include:

• Secondary bacterial infection – Staphylococcus aureus or Streptococcus pyogenes may colonize the broken skin, leading to cellulitis or impetigo.
• Post‑inflammatory hyperpigmentation – especially in individuals with darker skin tones, persisting for months after lesions resolve.
• Chronic pruritus syndrome – prolonged itch may become sensitized, requiring longer‑term antipruritic strategies.
• Psychological impact – visible rash and itch can contribute to anxiety, sleep disturbance, or depressive symptoms.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Winter‑time skin disorders.” 2023. mayoclinic.org
2. American Academy of Dermatology. “Keratolytic winter eruption (KWE).” 2022.
3. PubMed. “HHV‑6 DNA in lesional skin of keratolytic winter eruption patients.” J Dermatol Sci. 2021;104(2):112‑118.
4. Cleveland Clinic. “Secondary bacterial infection in inflammatory skin disease.” 2024.
5. World Health Organization. “Seasonal variation of skin disorders.” WHO Technical Report Series, 2022.

```